HIF-1α overexpression has been correlated with high risk of metastasis and high mortality in many human cancers, including breast cancer and renal cell carcinoma [15-17], whereas the molecular mechanism underlying its overexpression in osteosarcoma and potential impact on osteosarcoma progression have not been fully understood. This evidence concerns the gene HIF1A and breast carcinoma.